Literature DB >> 3932536

[In vitro susceptibility of recent clinical isolates of Rickettsia tsutsugamushi to chemotherapeutic agents].

S Miyamura, N Sato, A Tamura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3932536     DOI： 10.11150/kansenshogakuzasshi1970.59.486

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN： 0387-5911


× No keyword cloud information.
  5 in total

Review 1.  Antimicrobial therapy of rickettsial diseases.

Authors:  D Raoult; M Drancourt
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

2.  Orientia tsutsugamushi Is Highly Susceptible to the RNA Polymerase Switch Region Inhibitor Corallopyronin A In Vitro and In Vivo.

Authors:  Fredericke Kock; Matthias Hauptmann; Anke Osterloh; Till F Schäberle; Sven Poppert; Hagen Frickmann; Klaus-Dieter Menzel; Gundela Peschel; Kenneth Pfarr; Andrea Schiefer; Gabriele M König; Achim Hoerauf; Bernhard Fleischer; Christian Keller
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

3.  Antibiotic susceptibility of rickettsia and treatment of rickettsioses.

Authors:  D Raoult
Journal:  Eur J Epidemiol       Date:  1989-12       Impact factor: 8.082

4.  In vitro evaluation of josamycin, spiramycin, and erythromycin against Rickettsia rickettsii and R. conorii.

Authors:  D Raoult; P Roussellier; J Tamalet
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

5.  In vitro bacteriostatic effects of rifampin on Orientia tsutsugamushi.

Authors:  Jae-Hyoung Im; Ji Hyeon Baek; Jin-Soo Lee; Moon-Hyun Chung; Sun Myoung Lee; Jae-Seung Kang
Journal:  J Korean Med Sci       Date:  2014-01-28       Impact factor: 2.153
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.